Abzena, an integrated contract development and manufacturing organization (CDMO) for complex biologic molecules and antibody drug conjugates (ADCs), has appointed Sean O’Brien as senior vice president and site head at its San Diego manufacturing facility.

O’Brien will be responsible for leading and managing all site operations and applying his extensive knowledge across areas including regulatory approval and manufacturing process improvements to benefit customer programs.

O’Brien joins Abzena with more than 20 years of experience in the pharmaceutical industry, including positions at Alexion Pharmaceuticals and Amgen. He will leverage his extensive experience in leading organizations and driving business and network improvements to ensure that Abzena’s customers benefit from a biologics manufacturing service alongside the other capabilities the company offers.

“I was drawn to Abzena’s commitment to driving continuous improvements across its operations as it strives to help customers realize the full potential of their investments in human health,” said O’Brien. I am looking forward to driving the San Diego site through the next phase of company growth”.

Matthew Stober, CEO said: “Sean’s deep technical operations experience will ensure that Abzena can rapidly align to our customers’ needs and robustly respond to their customized program requirements. His deep expertise in process development, manufacturing and quality will ensure that we are aligning our market leading capabilities with the global customer needs.”